A carregar...
Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer
OBJECTIVE: Low-grade serous (LGS) ovarian and primary peritoneal cancer is a rare disease with limited therapeutic options. Low response rates are observed with cytotoxic chemotherapy. However, significant responses have been reported in patients treated with bevacizumab. The objective of this study...
Na minha lista:
| Publicado no: | Int J Gynecol Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4401424/ https://ncbi.nlm.nih.gov/pubmed/24978709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IGC.0000000000000190 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|